Unknown NA INTERVENTIONAL 2-arm NCT03885180

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy (REDUCE)

Randomized Evaluation of D-dimer Guiding Duration of Oral Anticoagulation Therapy in Patients With Bioprosthetic Heart Valves

Sponsor: Wuhan Asia Heart Hospital

Conditions Anticoagulants; Increased Valve Heart Disease

Interventions Warfarin Sodium

Updated 5 times since 2019 Last updated: Mar 24, 2019 Started: Mar 20, 2019 Primary completion: Mar 1, 2021 Completion: Mar 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anticoagulants; Increased and Valve Heart Disease and is currently ongoing. Wuhan Asia Heart Hospital leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Wuhan Asia Heart Hospital

Data source: Wuhan Asia Heart Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wuhan, China